The first botulinum toxin product, onabotulinumtoxinA, was approved by the FDA in 1989. Since then, FDA has approved several ...

Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...

The Food and Drug Administration has issued 18 warning letters to online retailers selling unapproved and misbranded Botox ...

The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

The FDA warning letters mostly went to cosmetic websites. In each case, the FDA said the companies were offering unofficial ...

Senators cite study showing 22 times higher serious side effects from chemical abortion drugs than FDA labels indicate, ...

“Unapproved and misbranded Botox products carry serious health risks. Today we’re taking action to protect American consumers and prevent online entities from selling these dangerous products,” said ...

The U.S. Food and Drug Administration (FDA) has approved two new biosimilars as reference products for Prolia (denosumab) and XGEVA® (denosumab): Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo ...

Botulinum toxin, commonly called Botox, is used to temporarily reduce wrinkles by paralyzing facial muscles. While it is considered safe, unapproved injections or counterfeit injections can come with ...

“The FDA approval of Lynkuet is an important new option for women and providers who are treating moderate to severe hot ...

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...

Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of ...